about
An improved ontological representation of dendritic cells as a paradigm for all cell typesCalmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cellsToll-like receptor signaling in vertebrates: testing the integration of protein, complex, and pathway data in the protein ontology framework.Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors.Logical development of the cell ontology.Hematopoietic cell types: prototype for a revised cell ontologyHIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling.Protein Ontology: a controlled structured network of protein entities.Phylogeny of Toll-like receptor signaling: adapting the innate response.OBIB-a novel ontology for biobanking.Cell surface expression of major histocompatibility class I antigens is modulated by P-glycoprotein transporter.Self-reactive antibody expression by human carcinoma cells engineered with monoclonal antibody genes.Characterization of monoclonal antibody 436 recognizing the Arg-Pro-Ala-Pro sequence of the polymorphic epithelial mucin (PEM) protein core in breast carcinoma cells.Correction: Toll-Like Receptor Signaling in Vertebrates: Testing the Integration of Protein, Complex, and Pathway Data in the Protein Ontology Framework.Hypervariable region 1 variant acting as TCR antagonist affects hepatitis C virus-specific CD4+ T cell repertoire by favoring CD95-mediated apoptosis.Antibody-selected mimics of hepatitis C virus hypervariable region 1 activate both primary and memory Th lymphocytes.Cyclic AMP modulates the functional plasticity of immature dendritic cells by inhibiting Src-like kinases through protein kinase A-mediated signaling.GPI-defective monocytes from paroxysmal nocturnal hemoglobinuria patients show impaired in vitro dendritic cell differentiation.Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women.Effects of human immunodeficiency virus type 1 on CD4 lymphocyte subset activation.Monoclonal antibody gene transfer. Implications for tumor-specific cell-mediated cytotoxicity.Clonal expansion of CD8+ BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia.Thymoma followed by paroxysmal nocturnal hemoglobinuria: a unique clinical association in the context of multiorgan autoimmunity with a potential role for CD8+ T lymphocytes.Thymoma-Associated Immunodeficiency: A Syndrome Characterized by Severe Alterations in NK, T and B-Cells and Progressive Increase in Naïve CD8+ T CellsFatal immunodeficiency in a patient with thymoma and Good's syndromeB-cell lymphopenia and hypogammaglobulinemia in thymoma patientsHuman equivalent of the mouse Nude/SCID phenotype: long-term evaluation of immunologic reconstitution after bone marrow transplantationImmunological findings in thymoma and thymoma-related syndromesCaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer
P50
Q21284365-1E19B592-E419-4F32-B1EF-6E28DB1D5FD9Q24295909-74AA4CC3-9BEE-4B26-8C8B-E8C86BFBD7BDQ30937032-5290730F-C59B-4CFA-AC7E-DC57D54E922FQ33604765-44DF3F59-A0D0-4106-9D6B-38954652BC94Q33604765-E733A428-4D42-4E64-8717-55A5B0ADBA75Q33786317-AFE9B9EC-4AFB-448A-8117-FAC5BE5DB68FQ33940690-F124E03E-28A8-4534-AB36-BAF4C9DC922DQ34230284-C008969A-AFBE-4A8C-BFF4-62E86A97E56DQ34387467-25EA5254-037C-41F4-90F0-3031A1F2AA5AQ34552210-C5172075-43E1-40BA-ADD0-56BEA1A88470Q36866845-ADB026CA-4E8D-4B27-AD25-B6918AB6A5F0Q41364979-A13E59E5-7D2E-4B31-A052-2F139EB0D4F3Q41542032-779F19E7-0D6A-435D-8EAB-3C85DD1AF39BQ41632431-C408E6F2-07DE-4E77-9748-56C28EFBED22Q42423839-C82149BB-70A9-45DD-8B08-65567BFF9986Q42992804-F54E7F24-3283-4E31-9C81-8921F28F92AAQ43046853-A9D9D78C-51A0-400E-A296-CDE6017D2EF4Q44912942-CCDAECE9-EB98-4671-AEBF-21DBB6EC7075Q44936649-44424A91-D5C1-4B14-8F60-014480391704Q45740268-3DB419ED-A91B-46D3-8FA6-1832AD2E258BQ45748760-B307C944-56DE-41BE-BA2A-5A9E7BF5CF86Q46149201-DA019CE0-6945-4B07-BC14-6138DC20639BQ51691630-8871C23A-C1A7-4B7C-AF88-CA4D4A88F520Q51795936-27A66F5D-34B9-48B5-9AE6-55C45B2F3EDFQ58370821-8ABF1A51-4B8D-40FF-B81C-A4FFA26748CDQ60953297-0158A8E6-8EF9-4DB0-9A27-532E9561DC04Q60953332-81E99F53-F3EF-4D44-BB2E-37D27E6AFF24Q60953352-9FB4A530-569B-4F23-B03C-468E0C0FC674Q60953374-2F1CD864-23DB-47E9-92FC-F668DCDA0FAAQ92525406-D353C546-6CDD-4CF3-A847-ED69C9D05A84
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Maria Masci
@ast
Anna Maria Masci
@en
Anna Maria Masci
@es
Anna Maria Masci
@nl
Anna Maria Masci
@sl
type
label
Anna Maria Masci
@ast
Anna Maria Masci
@en
Anna Maria Masci
@es
Anna Maria Masci
@nl
Anna Maria Masci
@sl
prefLabel
Anna Maria Masci
@ast
Anna Maria Masci
@en
Anna Maria Masci
@es
Anna Maria Masci
@nl
Anna Maria Masci
@sl
P108
P106
P108
P1153
6701535257
P21
P31
P496
0000-0003-1940-6740